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Background: At the points where an infectious disease and risk factors for poor health intersect, while health problems
may be compounded, there is also an opportunity to provide health services. Where human immunodeficiency virus
(HIV) infection and alcohol consumption intersect include infection with HIV, onward transmission of HIV, impact on HIV
and acquired immunodeficiency syndrome (AIDS) disease progression, and premature death. The levels of knowledge
and attitudes relating to the health and treatment outcomes of HIV and AIDS and the concurrent consumption of alcohol
need to be determined.
This study aimed to ascertain the knowledge, attitudes and practices of primary healthcare workers concerning the
concurrent consumption of alcohol of clinic attendees who are prescribed antiretroviral drugs. An assessment of the
exchange of information on the subject between clinic attendees and primary healthcare providers forms an important
aspect of the research. A further objective of this study is an assessment of the level of alcohol consumption of people
living with HIV and AIDS attending public health facilities in the Western Cape Province in South Africa, to which end, the
study reviewed health workers’ perceptions of the problem’s extent. A final objective is to contribute to the development
of evidence-based guidelines for AIDS patients who consume alcohol when on ARVs. The overall study purpose is to
optimise antiretroviral health outcomes for all people living with HIV and AIDS, but with specific reference to the clinic
attendees studied in this research.
Methods: Overall the research study utilised mixed methods. Three group-specific questionnaires were administered
between September 2013 and May 2014. The resulting qualitative data presented here supplements the results of the
quantitative data questionnaires for HIV and AIDS clinic attendees, which have been analysed and written up separately.
This arm of the research study comprised two, separate, semi-structured sets of interviews: one face-to-face with
healthcare workers at the same primary healthcare clinics from which the clinic attendees were sampled, and the other
with administrators from the local government health service via email. The qualitative analysis from the primary
healthcare worker interviews has been analysed using thematic content analysis.
(Continued on next page)* Correspondence: mschneider@global.co.za
1Alcohol, Tobacco and Other Drug Research Unit (ATODRU), Medical
Research Council, P O Box 19070, Tygerberg 7505, Cape Town, South Africa
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Schneider et al. Globalization and Health  (2016) 12:65 Page 2 of 12(Continued from previous page)
Results: The key capacity gaps for nurses include the definition of different patterns and volumes of alcohol
consumption, resultant health outcomes and how to answer patient questions on alcohol consumption while on
antiretroviral treatment. Not only did the counsellors lack knowledge regarding alcohol abuse and its treatment, but they
were also they were unclear on their role and rights in relation to their patients. Doctors highlighted the need for
additional training for clinicians in diagnosing alcohol use disorders and information on the pharmacological
interventions to treat alcoholism.
Conclusion: Pertinent knowledge regarding patient alcohol consumption while taking ARVs needs to be disseminated to
primary healthcare workers.
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Research indicates that worldwide, South Africa has the
highest number of new HIV infections, the largest public
sector antiretroviral treatment (ART) programme [37],
and one of the highest levels of alcohol consumption per
drinker [40].
Alcohol consumption likely plays a key but under-
acknowledged role in HIV disease progression and sur-
vival [13]. The interface between alcohol consumption
and HIV and AIDS has been largely overlooked in public
health research [18]. A recent review of research into al-
cohol and HIV in Sub-Saharan Africa highlights the lack
of research on the association between alcohol use and
HIV disease progression [31]. Alcohol consumption is
common, however, among those with HIV infection,
with usage ranging from 37 to 68 % and hazardous usage
from 5 to 28 % in selected populations [14]. Results from
a meta-analytic review of published studies examining
the association of alcohol use and ART adherence, sup-
port a significant and reliable association of alcohol use
and medication non-adherence [21]. Studies have dem-
onstrated a temporal and dose-response relationship be-
tween alcohol consumption and non-adherence to
ARVs, with non-binge drinkers missing more doses than
non-drinkers, and binge drinkers missing more doses
than non-binge drinkers [6]. Furthermore, binge drink-
ing rather than the cumulative exposure of hazardous
drinkers was predictive of non-adherence to ART [7]. A
recent study conducted in HIV clinics in Tshwane, Gau-
teng province in South Africa, found a significant associ-
ation between level of alcohol use and degree of non-
adherence [27].
South Africa’s average alcohol consumption in 2010
was 10 % above the global average at 27.1 l of pure alco-
hol per annum [40]. In South Africa in 2010, the preva-
lence of alcohol use disorders (AUDs) and alcohol
dependence were respectively 10 and 4 % in men and
1.5 and 0.7 % in women. These figures are three times
higher than the average for the whole of Africa [40].
Findings by Azar et al. [2] support an associationbetween AUDs and decreased adherence to antiretroviral
therapy, and poor HIV treatment outcomes among HIV-
infected individuals.
The increased life expectancy for HIV-infected indi-
viduals made possible by ART increases the cumula-
tive competing risk of long-term adverse outcomes
associated with alcohol consumption [14]. Further-
more, the wider availability of ART may lead to an
increase in risky behaviour. Shisana et al. [37] stress
that this risk, termed “risk compensation”, needs to
be reduced.
An American study [36] examined the influence of pa-
tient beliefs about alcohol on ART adherence and eluci-
dated clinician beliefs about drinking and taking ART.
Most patients (85 %) believed alcohol and ART should
not be mixed. Alcohol was found to affect adherence
through a decision to skip ART doses when drinking ra-
ther than through drunken forgetfulness. In addition,
more than 50 % of clinicians believed alcohol and ART
should not be taken together. These findings have impli-
cations for patient care and training for clinicians in this
domain. Given the scaling up in recent years of the ARV
roll-out in the South African public health sector [12] in
response to the twin goals of high ARV coverage and op-
timal ARV treatment outcomes, ineffective antiretroviral
therapy management, particularly at primary healthcare
level, would result in adverse health outcomes and wast-
age of scarce health resources.
In South Africa, primary healthcare workers (PHCWs)
in ART clinics are responsible for life-long treatment
and support to avert exacerbation of the existing health
condition. The PHCWs also play a prevention role, spe-
cifically for the onward transmission of HIV. In terms of
ART management options, Callaghan et al.’s [10] litera-
ture review found task shifting to be a feasible means of
addressing human resource shortfalls in HIV care in
sub-Saharan Africa. Task-shifting in this context involves
shifting some health services to less qualified personnel.
Bearing in mind the under-resourced public health
services, high HIV prevalence and an expanded ART
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retroviral treatment, a research study was conducted in
the public health sector in the Western Cape Metro re-
gion of the Western Cape, a province in South Africa.
The eight sample ART clinics were located in, or drew
patients from under-privileged communities, which
means the patient pool can be considered fairly
homogenous in terms of the social determinants of
health that have an impact on alcohol misuse, HIV in-
fection and access to health services.
The study aims to gauge knowledge levels and under-
standing of both ART clinic attendees and the PHCWs
of the implications of alcohol consumption while taking
ARVs. This paper focuses on the PHCWs (medical doc-
tors, nurses, ART counsellors). We ascertained the
PHCWs understanding of the interface between alcohol
and HIV and the kinds of information they were impart-
ing to healthcare service users on the adverse effects of
alcohol use and the adverse effects of alcohol consump-
tion on the course of the disease.
A further objective of this study is to present PHCWs’
assessment of the level of alcohol consumption of people
living with HIV and AIDS (PLHA) who attend public
health facilities in the Western Cape Province in South
Africa. Given the apparent absence of an international
best practice standard, or national, provincial or other
guidelines on alcohol consumption and ART, the study
endeavours to establish whether there are any internal
clinic guidelines in this respect, and in addition, PHCW
and health service administrator views on the availability
of such guidelines. The overarching study purpose is to
optimise ART outcomes, contributing to the develop-
ment of evidence-based guidelines for AIDS patients
who consume alcohol while on ARVs is also an import-
ant objective in this regard.
Methods
Design
This study employed qualitative research methods and
was cross-sectional in nature.
Sampling
The study involved eight sets of three PHCWs, and two
health service administrators at local government level.
Data was collected by key informant interviews with
PHCWs (medical doctors, nurses, ART counsellors) at
primary healthcare clinics located in Western Cape
Metro region, which comprises eight sub-districts: East-
ern, Khayelitsha, Klipfontein, Mitchell’s Plain, Northern,
Southern, Tygerberg and Western. The two key infor-
mants at local government level were interviewed using
a separate semi-structured questionnaire.
Three staff members, an ART counsellor, a doctor and
a nurse, were interviewed to determine the level ofhealthcare worker knowledge at primary level clinics dis-
pensing ART in the public health sector regarding the
effect of alcohol consumption combined with antiretro-
viral drugs. The facility manager allocated the PHCWs
to be interviewed, making recruitment for each cohort
by convenience sampling. Interviews were conducted
with three PHCWs, one from each cohort, in each of the
eight selected clinics, that is, 24 interviews with PHCWs
in total.
City Health manages the clinics and the Provincial de-
partment of health is responsible for hospitals and most
of the community health centres. Interviews were con-
ducted with a designated administrative staff member re-
sponsible for implementing the South African roll-out of
ART programmes in the City of Cape Town and the
Western Cape Government, respectively. These inter-
views ascertained policy directives and guidelines on al-
cohol consumption while on ART.
Study instruments
The questions on the PHCW and health service admin-
istrator questionnaires were open-ended, with each
question having a series of prompts for the respondents.
Besides determining knowledge and understanding in
this research area, the semi-structured questionnaire (for
PHCWs) probed attitudes and practices relating to alco-
hol consumption and ART, as well as the difficulties
PHCWs experience pertaining to ARV regimen adher-
ence for clinic attendees.
Study procedures
Over the course of a week, an experienced research pro-
ject manager gave fieldworkers training that included
training workshops on interviewing skills and tech-
niques, and lecture on research ethics. The latter cov-
ered the process of obtaining informed consent from
participants and emphasising the confidentiality of the
questionnaire content with assurances that answers
could not be linked to individual respondents.
Interviewees gave written, informed consent and
granted permission to have the interview recorded. In
addition, notes were taken, capturing the responses to
the semi-structured interviews as they were conducted.
For quality control, the project manager sat in on six of
the interviews for which the interviewees granted per-
mission. Interviewees made an informed and voluntary
decision about accepting or declining participation in
the study.
Ethics approval for the research was obtained from the
University of Stellenbosch, (Ethics reference number:
N11/07/223), and the research protocol was edited to
match the design and analysis requirements of the fund-
ing facilitators, namely, the United States Centers of Dis-
ease Control and Prevention.
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PHCW groups from the eight clinics in the study, data
was also compared from each of the three groups of
healthcare workers at one randomly selected clinic out
of the eight sample clinics.
The research element involving the health service ad-
ministrators necessitated contacting the City of Cape
Town and Western Cape Province offices to ascertain
the details of a spokesperson with knowledge of the
working of ART programmes from each office. These in-
dividuals were contacted by telephone to introduce the
research project. After agreeing to participate, they com-
pleted the questionnaires and emailed them to the prin-
cipal investigator (MS). These administrative officers
completed a separate, semi-structured questionnaire to
the one conducted with the PHCWs. This data collec-
tion occurred in parallel to the PHCW data collection.
Examples of questionnaire questions
The investigation focused firstly on whether the PHCWs
perceive alcohol consumption as a problem among the
clinic population and the community from which the
clinic draws its patients. A further question posed con-
cerned PHCWs’ perceptions of the nature of the patient-
service provider relationship, and in particular how the
PHCWs view their role in relation to patients who abuse
alcohol. The extent to which taking ARVs and drinking
alcohol occurred simultaneously was explored by asking,
for example, whether participants believed that clinic at-
tendees intentionally skip ARV doses when drinking or
intending to drink.
Health service providers were also asked whether there
were clear guidelines for patients concerning the concur-
rent use of alcohol and ARVs. The questionnaires ascer-
tained PHCW views on unmet needs relating to training
and information dissemination on the role of alcohol
consumption and the course of HIV and AIDS. Inter-
views were conducted with the health service adminis-
trators to determine official health service policy
guidelines in this domain. To this end, this group’s ques-
tionnaire probed current policy directives and guidelines
on alcohol consumption while on ART.
Data analysis
All 24 PHCW interview recordings were transcribed and
subjected to thematic content analysis [17]. The tran-
scripts were then checked against specific knowledge
items relating to alcohol abuse and its treatment, and
whether the PHCWs knew what constituted sensible or
non-risky drinking for PLHA. The specific knowledge
items were found in the Diagnostic and Statistical Man-
ual of Mental Disorders-IV, (DSM-IV), [1] which defines
the alcohol use disorders, namely, alcohol dependence
and alcohol abuse. Other knowledge items were foundin the Alcohol Use Disorders Identification test (AUDIT)
[9], which is used to assess patients’ alcohol use and tim-
eously detect hazardous and harmful alcohol use in pri-
mary healthcare settings.
The principal investigator analysed all the transcripts
and an independent researcher in qualitative research
analysed a sample of randomly drawn transcripts from
the three batches. The themes emerged as a result of
reading and comparing the respondent opinions in the
transcripts and determining the most common re-
sponses. Illustrative quotes pertaining to these themes
are provided in the text.
Coherence in terms of knowledge, information dissemi-
nated and a common policy agenda within a particular
clinic was also examined as well as how the different
PHCWs within the sample clinics viewed each other’s
roles in this area. This aimed to ascertain whether there
were within-clinic differences among PHCWs and to
compare these to the findings across the different clinics.
The principal investigator and the project manager
reached consensus by independently comparing the
completed questionnaires from the two health service
administrators and discussing the findings.Results
Main themes emerging from the PHCW interviews
PHCWs had different types of expertise and various
levels of and training and experience at different levels
across clinics. The emerging themes within the different
groups point towards specific interventions being re-
quired for each level of PHCW to improve service in the
primary healthcare clinics.Interviews with doctors
The doctors emphasised to patients that reactions be-
tween alcohol and ARVs make the ARVs less effective.
They also stressed the negative effect of alcohol on the
liver and that a damaged liver cannot process the ARVs.
Patients with tuberculosis or hepatitis were told to avoid
alcohol completely.
Besides the clinical effects of alcohol use on ART, the
most important outcome for the physicians was the im-
pact of alcohol use on ART compliance. For the clini-
cians, the main issue with alcohol consumption, heavy
drinking in particular, was that patients defaulted on
treatment. More than one doctor mentioned having to
be careful about telling patients not to mix alcohol and
ARVs as alcohol would be chosen above the ARVs. Pa-
tients were, however, generally told to take their medica-
tion irrespective of whether they were drinking or
intending to drink alcohol. One doctor went so far as to
advise patients to “take their ARVs with alcohol” rather
than stop treatment; another reported that community
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or taverns.
An important aspect of the clinicians’ knowledge in this
domain is expertise in screening for alcohol problems,
diagnosis of AUDs and required interventions for prob-
lematic alcohol use. It is also important to ascertain
whether clinic attendees know the definition of harmful
drinking. The doctors were familiar with the Cutting
down, Annoyance by criticism, Guilty feeling and Eye-
openers (CAGE)1 questionnaire, but less so with the Alco-
hol Use Disorders Identification Test (AUDIT). They were
aware of organisations for substance abuse treatment,
such as the South African National Council on Alcohol-
ism and Drug Dependence (SANCA). Those interviewed
did not know about Brief Interventions (BIs) to treat alco-
hol problems, with the exception of one doctor, they were
generally not acquainted with the term “binge drinking”2
and they did not know of policy guidelines relating to
ART and concomitant alcohol consumption.
Some of the clinicians were unsure of the clinical stan-
dards used for diagnosing AUDs; furthermore, they did
not mention either the World Health Organization, Inter-
national Classification of Disease-10 ICD-10, [39], or
American Psychiatric Association: Diagnostic and Statis-
tical Manual of Mental Disorders-IV, (DSM-IV), [1] classi-
fication systems. They also had no detailed knowledge of
pharmacological interventions to treat alcoholism. One
doctor said he would welcome additional training on sub-
stance abuse and ARVs and another suggested that once
screened and identified as having an alcohol problem, the
patient should be referred to a rehabilitation centre as
given the high patient volume and workload they would
be unable to provide adequate follow-up.
Different reasons were given for the heavy workload
by the different healthcare practitioners. Generally, it
was not the number of patients per se, but the nature of
the presenting medical problems that were identified as
time consuming. One doctor mentioned that advanced,
complicated or adherence-lapsed cases took longer, and
that in addition, when administrative systems were not
sufficiently effective to allow quick access to patient re-
cords, delays were inevitable.
Besides substance abuse, the doctors mentioned sev-
eral other factors that resulted in non-adherence to
ART, including “pill fatigue”, depression and non-
disclosure of their HIV status. It was mentioned that
non-adherence might be indirectly related to alcohol
consumption, either the patient’s own or that of other
family members. A patient with an abusive partner abus-
ing alcohol may seek shelter elsewhere, away from home
and the clinic, and as a result default on ART.
The doctors’ comments about the ART counsellors in-
cluded the following: “lack basic knowledge of HIV and
AIDS” and “should be better trained”. One respondentrecommended that the counsellor’s role should be ex-
tended beyond the initiation of ART and the follow-up
of defaulters to include counselling for substance abuse.
Another stated that the counsellors “can benefit from
more training on substance abuse”. Doctors found that
some clinic attendees were illiterate and in general did
not appear to have community support.
Interviews with nurses
The nurses were familiar with the CAGE assessment for
alcohol abuse [15], while a few also knew about the
AUDIT questionnaire [9]. They were not aware of policy
guidelines with regards to alcohol and ART and had no
knowledge of BIs. A few were familiar with SANCA but
they were not well-informed about medication for alco-
holism and most of them could not define “binge drink-
ing”. The nurses would appreciate training to deal with
substance abuse for HIV-positive patients and also be-
lieve that the counsellors’ role should be extended to
focus on substance abuse.
They understood that certain ARVs are contraindi-
cated for alcohol, for example, one nurse stated that Efa-
virenz cannot be taken with alcohol as it is
hallucinogenic, and that Nevirapine and alcohol both
have a negative impact on the liver. Gauging from their
responses to the questionnaire, the nurses recognised a
worsening of co-morbid conditions such as TB, epilepsy,
diabetes and other cardio-vascular diseases when HIV
patients drink excessively.
Some of the respondents felt that because of the client-
service provider relationship, they were in a position to
address alcohol problems without being judgmental.
Others felt that the opposite was true, that is broaching
the subject of alcohol consumption may harm the patient-
service provider relationship: “People should be allowed to
live their lives”. One respondent maintained that “there is
not much we can do for patients who consume alcohol–
this is the way they cope in their community”. One inter-
viewee even maintained that those who drink and take
their ARVs have suppressed viral loads.
Usually the defaulters were patients with alcohol prob-
lems while some of the patients defaulted due to logis-
tical problems with access to ARVs. Non-adherence was
also linked to the stigma related to HIV as some patients
had not disclosed their status to co-habitees and there-
fore did not want to be seen taking their ARVs. Nurses
mentioned that when first-line treatment failed, a num-
ber of patients had needed to go on second- and even
third-line treatment for AIDS, the latter being more
complex with more side-effects. In general, the nurses
stated that patients were often in denial concerning their
HIV status and tended to be poorly informed and lack-
ing in knowledge of matters pertaining to their health
and well-being.
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The counsellors emphasised to the patients that ARVs
are life-long medication: “ARVs is not a Panado, just for
now”. They maintain that while alcohol consumption
often results in missed ARV doses, the person could also
default on treatment, i.e. stop taking ARVs for an ex-
tended period of time. The counsellors mentioned that
besides passing out from excessive alcohol consumption
and missing ARV doses, the patients did not always re-
member whether they had taken their ARVs and there-
fore overdosed. Clinic appointments are pre-booked and
patients may miss or arrive late for appointments if
drunk. Non-attendance at the clinic as scheduled is an
aspect of non-adherence for ART that is monitored.
Counsellors were generally not knowledgeable about
BIs or the AUDIT, while some were familiar with the
CAGE or medication for addiction and the term “binge
drinking”, and commonly said that no policy guidelines
on alcohol consumption and ART were available. Some
had heard of SANCA or similar organisations. They
would also like more training to deal with substance
abuse. The counsellors had some knowledge of alcohol
and ARV interactions and knew that both alcohol and
ARVs are metabolised in the liver and thus that alcohol
impacts negatively on ARV efficacy. The counsellors
contended that many patients were illiterate and that to
some extent this impeded the counselling process.
Expanding on particular difficulties with patients abusing
alcohol, they noted that when alcohol was used as a cop-
ing mechanism: “… when they cannot accept the fact
that they are living with the virus they end up drinking
when they never drank before”.
Furthermore, the counsellors held that patients were
dishonest about their alcohol use. In this study, there
was evidence of the dual stigmas related to alcohol con-
sumption, and HIV and AIDS. The stigma associated
with alcohol consumption results in patients often not
being forthcoming about the extent of their alcohol con-
sumption. “… if you telling a patient that’s smelling of
wine that ‘excuse me are you intoxicated?’ they will say
‘No, are you mad? It’s Tuesday I drank on Saturday, I
just didn’t wash my clothes, but I drank on Saturday and
I didn’t brush my teeth for three days’, you know things
like that they will tell you…” This demonstrates that
even if patients admit to drinking alcohol they are not
entirely truthful and do not give accurate information
concerning the volume and patterns of their alcohol use.
One counsellor stated that she had difficulty dealing
with some patients who were abusing alcohol as they
were adept at concealing the problem and were in denial
that they even had a problem.
The stigma linked to HIV-status sometimes results in
the non-disclosure of a person’s HIV status. One
counsellor stated that: “It is the young ones that don’tdisclose to their partners because they going to lose their
relationship.” The non-disclosure of HIV status to intim-
ate partners because of the stigma associated with HIV
and AIDS may result in patients not taking ARVs. The
individual on ART may not want to be seen taking anti-
retroviral drugs: “… every time she goes into the bath-
room she takes her toilet set because in the set there are
ARVs, say that day you are lazy to take a bath that
means that day you won’t take medication.” Non-
adherence in turn has implications for optimal clinical
patient management.
The counsellors were aware of the need for counsel-
ling for substance abuse. “If he goes for alcohol I can say
that he needs counselling to deal with this matter”. Some
patients go to Alcoholics Anonymous (AA) and “then
just don’t go anymore”.
One interviewee said she did not have a right to tell
her patients not to drink while others tended to have a
resigned attitude to patients with such a problem.
“Everybody drinks, it is part of the culture” and “you
cannot tell people to stop drinking…they will continue
drinking no matter what we say”. In general, they rec-
ommended reducing the amount of alcohol consumed.
“I’m not saying don’t drink, seeing that you are already
addicted to alcohol, just drink within limits, but what’s
important is that your treatment comes first”. If a pa-
tient arrives at clinic inebriated, medication cannot be
withheld. The best they can do is to provide the ARVs
and ask the patient to come back sober the next day
with a relative or friend to whom they have disclosed
their HIV status.
Congruence of knowledge and perception of roles among
PHCWs at one specific clinic
While PHCWs’ information and knowledge differed
across the clinics sampled, it also differed within clinics.
This was demonstrated in the study by comparing infor-
mation received from the three PHCW groups at one
randomly selected clinic.
At the clinic under scrutiny, discrepancies were noted
among the three cohorts of health workers in their levels
of knowledge and in particular, whether there were pol-
icy guidelines on alcohol consumption and ARVs. Per-
ceptions of competence among the healthcare providers
at this clinic, in terms of providing adequate information
to patients, corresponded to those observed in the study
as a whole.
For example, looking at the interview responses to
gauge levels of knowledge pertinent to alcohol use and
ART, the counsellor seemed less informed than the doc-
tor and the nurse. The doctor stated that he “did not
know the depth of the counsellor’s knowledge.” The
nurse attributed the lack of adherence to ART to: “…
not enough information given to them (patients) when
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sellor’s role in educating patients beginning to use ARVs.
Furthermore, the doctor said that his job was made eas-
ier by patients already having seen the counsellor and
nurse when they came to an appointment with him as
he was able to build on a foundation of knowledge
already laid by the other clinic staff. This assumption,
however, may not be valid as nurses identified lack of
sufficient information transfer in the counselling process
as a reason for non-adherence to ARVs. The counsellor
stated: “People even if they do start the treatment they
ask, ‘Hey Sisi [counsellor] can I take a glass of wine?’ and
you don’t know what to say to the patient”. The
counsellor said she would like to attend workshops to
answer these types of questions.
At the clinic where the interviewee responses were
compared, alcohol abuse was not considered the fore-
most problem. All three PHCWs found it difficult to
quantify the extent of the problem, saying they relied on
the questions relating to alcohol use that were part of
the stationery, i.e. the CAGE questions, in the patient
files.
All the healthcare practitioners at the same clinic felt
that they could easily identify those who came to the
clinic intoxicated. For the nurses, the discernible symp-
toms included red eyes, irritability, the reek of alcohol or
“iphuzo face,” a colloquialism for a hangover. The doc-
tors listed symptoms such liver function test abnormal-
ities or Dupuytren’s contracture as symptoms indicative
of alcohol misuse.
Their views on the availability of policy guidelines
were mixed. The doctor and counsellor claimed that
there were no policy guidelines on alcohol consumption
and ARVs. The nurse claimed there were very clear
guidelines, but did not elaborate further. She claimed
that those who abuse alcohol should not start ARVs be-
cause “of the risk of the starting medication, stopping
medication and developing (drug) resistance at the end
of the day”. The counsellor said that she advises patients
to cut down or stop drinking alcohol when starting ARV
medication. The doctor said the amount of alcohol con-
sumed by the patient guided his advice to the patient re-
garding alcohol consumption and ARVs and stressed not
taking ARVs and alcohol together since the alcohol in-
hibits absorption of the ARVs.
Extent of the alcohol problem
The clinics in the study provided a wide range of esti-
mates on the extent of alcohol abuse. At the clinic where
the responses were compared, all three PHCWs agreed
that alcohol consumption was not the foremost problem.
Three other estimates emanating from the doctor, nurse,
and counsellor groupings in three randomly selected
clinics in the sample yielded widely differing estimateson the extent of the problem. It may be that alcohol
problems are higher in some communities and it would
be useful to identify the clinics serving these communi-
ties and focus on training at these clinics.
Health service administrator interview results
The administrative officials had quite different views on
the availability of guidelines on alcohol consumption
and ART.
One claimed that there were specific guidelines for
HIV-positive patients such as those relating to avoiding
alcohol when on TB medication, but that no specific ad-
vice was given regarding alcohol consumption together
with taking ARVs. The other respondent said there were
no specific guidelines on alcohol consumption for HIV-
positive patients in the public health sector. Both re-
spondents, however, considered it inadvisable to mix
ARVs and alcohol. The adverse effect of alcohol on the
immune system and the fact that consumption nega-
tively affects resistance to diseases and interferes with
the breakdown of medications in the body was dis-
cussed. Other aspects such as the effect of alcohol con-
sumption on liver disease were not emphasised.
One interviewee highlighted mixed messages as ab-
stinence from alcohol consumption and drinking within
normal safe limits were both endorsed. A further re-
sponse was that ARVs were not withheld when a person
was deemed to have a problem with alcohol consump-
tion. The other respondent said that this would depend
on the patient’s behaviour, for example, the patient’s
clinic attendance.
Discussion
Notwithstanding the PHCWS having different types of
expertise and various levels of training and experience,
analysis of the interviews points to inadequacies in the
domain under study. The study shows a scarcity of
counselling skills and the lack of clarity for PHCWs re-
garding guidelines on alcohol use when on ART. Other
problems identified included misunderstanding of
PHCWs’ recommendations and misinformation among
ART clinic attendees concerning alcohol consumption
and the simultaneous use of ARVs.
Research by Burman et al. [8] found that most primary
care patients who misused alcohol did not receive alco-
hol counselling from their care providers. The PHCWs
predominantly advised abstention. McCormick et al.
[29] also found that most providers did not educate their
primary care patients about recommended drinking
limits. The study found that uneasiness on the part of
the provider during alcohol-related discussions was an
important barrier to evidence-based, brief alcohol coun-
selling. The lack of knowledge and other interpersonal
factors also play a role here. The findings from this study
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corroborate this.
Standard drinking guidelines for HIV-positive patients
and those on ART may not exist. Drinking guidelines for
people on ARVs may depend on, inter alia, past alcohol
consumption and the general state of health which in-
cludes other co-morbidities, the length of time on ART
and the hepatotoxicity of certain ARVs. In terms of
drinking guidelines for PLHA, Justice et al. [22] found
no evidence of a “safe” level of alcohol consumption,
while Conigliaro et al. [14] stated that the quantity and
frequency of consumption constituting a measurable
harm for HIV patients has not been determined, but
would probably be lower than the amounts recom-
mended for the general population. People with HIV
have a lower tolerance for alcohol [7, 30] and hence
should be informed accordingly.
In addition to the scarcity of such information for
people on ART, there is the problem of misinterpreting
available recommendations. For example, the doctors in
this study reported that although patients are told that
drinking alcohol and taking ARVS is inadvisable, the pa-
tients still jettison the ARVs and choose to drink instead.
The findings from a prospective cohort study [25] con-
firmed those of an earlier cross-sectional study, [24] that
a substantial number of people intentionally skip or stop
their medication when drinking. Multivariate analyses
showed that interrupting ART when drinking alcohol
occurred over and above other common correlates of
non-adherence, including the frequency of alcohol con-
sumption itself [24]. ART interruptions also occur in re-
sponse to a belief, termed, interactive toxicity belief.
This unfounded belief goes beyond the cognitive effects
of alcohol intoxication and results in the interruption
ART as a deliberate choice based on the belief that mix-
ing alcohol with medications will lead to adverse health
reactions. Some of the doctors interviewed specifically
referred to interactive toxicity beliefs, although they did
not use this terminology. Missing medication doses
when drinking for whatever reason threatens the long-
term benefits of treatment [23].
The non-disclosure of alcohol use by patients has been
identified as problematic. The non-disclosure of alcohol
consumption stymies the identification of problem
drinkers. A study by Hahn et al. [19], a first for sub-Saharan
Africa, showed that when a biomarker measurement of al-
cohol exposure such as a breath test is conducted together
with a survey, the self-reporting of alcohol consumption
improves. It may therefore be necessary to include such in-
expensive and non-invasive ways to improve the self-
reporting of alcohol consumption.
The South African healthcare system currently focuses
on providing tertiary care services for the treatment of sub-
stance dependence where there is often a poor outcome.This focus needs to shift towards the cost-effective strategy
of providing BIs early on for alcohol use disorders [35].
PHCWs at the ART clinics selected for the study do
not receive adequate training on substance abuse. They
generally have no knowledge of the definition of alcohol
misuse or the recommended guidelines for moderate
drinking. Although not particularly knowledgeable about
HIV and AIDS and concomitant alcohol consumption,
they are aware that an important component of treating
such patients is reducing and keeping alcohol consump-
tion to a minimum with the eventual aim of complete
cessation.
At the clinic where the responses of the three PHCWs
were compared, the results indicated a general lack of
consensus concerning information in this domain; the
information was not coherent and no clear treatment
guidelines were provided. For the PHCWs there could
also be different interpretations of what constitutes
guidelines.
From the third tier interviews at administrative level,
no comprehensive guidelines for PHCWs appeared to
exist to inform patients about the negative effects of
consuming alcohol at the time of, before, or subsequent
to taking ARVs. The consumption of alcohol while on
ART was not considered to be a priority public health
concern. This is in line with what Fritz et al. [18], refer
to as the “conspicuous absence” of alcohol from HIV
and substance use research and programming. They sug-
gest that the pervasiveness of alcohol use is the reason
why the insidious role of alcohol consumption in the
HIV epidemic has been overlooked.
Limitations
Biomarkers were not used to validate the clinic attendees’
self-reporting of their consumption of alcohol. Further-
more, PHCWs reported that they did not employ alcohol-
use screening tools to detect AUDs or less grave alcohol
use problems for the clinic attendees in this study. The
lack of biomarker use and alcohol-use screening tools
thwarts optimal patient care in this domain. It may be that
clinic attendees’ alcohol consumption is not considered to
be sufficiently relevant for ART optimisation.
The Adult AIDS Clinical Trials Group, [11] an instru-
ment for measuring levels of adherence to ART and rea-
sons for missed doses, was not used to analyse the
transcripts but could be considered for use in future re-
search in this area focusing on adherence measurement.
Overall, the findings based on interviews with PHCWs
in part of the Western Cape province may not be applic-
able to the other eight provinces in South Africa, (or
even other parts of the same province), as they have dif-
fering population compositions and administrations.
The selection of nurses and counsellors and doctors
was not a random procedure. The managers may have
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assigned more experienced personnel to be interviewed.
This sampling may have resulted in a skewed PHCW
sample and the findings therefore may not apply to less
experienced clinic staff. Furthermore, only one doctor
may have been working at the particular clinic and this
clinician would be interviewed.
For the third tier of interviews, only two health service
administrators were interviewed. Additional information
on policy guidelines in the Western Cape metropole
may have been obtained by interviewing other adminis-
trative personnel.
Conclusions
Clear prevention and treatment guidelines should be
drawn up for PHCWs and patients at ART clinics con-
cerning alcohol consumption for patients on ARVs as
well as treatment-naïve patients. Although the intercon-
nections between alcohol use and the disease course of
HIV and AIDS have not been fully delineated, guidelines
regarding alcohol consumption and HIV treatment are
nevertheless needed for clinic attendees. Results from
this survey to assess knowledge and practices around
HIV and alcohol consumption can contribute to such
guidelines. These contributions include indicating where
relevant information is not available. Healthcare pro-
viders could use these guidelines for their patients
resulting in improved HIV treatment at primary health-
care level. Longer-term, it is anticipated that there would
be buy-in from relevant stakeholders, including provin-
cial and national health governments, clinicians, nurses
and counsellors, which would hopefully influence public
health initiatives impacting on the interface of ART and
harmful alcohol consumption.
The study results also indicate that the service pro-
viders need additional information and training to ad-
dress substance abuse in PLHA. Further training is
essential for primary healthcare service providers, specif-
ically ART counsellors in the Western Cape and expli-
citly on antiretroviral medication and the concomitant
drinking of alcohol.
Nurses and counsellors at ART clinics need more in-
formation on both the negative direct and indirect ef-
fects of alcohol consumption for their patients. These
include additional information and education around,
for example, the direct negative effect of alcohol on the
immune system and the indirect effects of alcohol on
HIV treatment adherence and treatment outcomes [5].
Improve levels of information
Once the level of knowledge in the target population has
been determined, it is necessary to build on it, which in-
cludes educating the community at large, extending treat-
ment networks and disseminating pertinent information.As well as nurses and counsellors at the ART clinics, HIV
clubs, treatment buddies, community care workers, social
workers and psychiatric nurses should receive information
and training about substance abuse and ways to facilitate
necessary behaviour change interventions. This informa-
tion should include where to seek specialised help if
necessary.
Local communities can be educated on the negative ef-
fects of alcohol on HIV and AIDS prognosis by provid-
ing health information material in the form of brochures
and posters in the clinics and incorporating expanded
information levels using social networks that include
peer educators and HIV-clubs. The latter operate to pro-
vide medication to stable ART patients.
Address misinformation
More information needs to be made available, specific-
ally for clinic attendees, and misinformation needs to be
addressed concerning alcohol consumption while taking
antiretroviral drugs. In particular, interventions are
needed to correct alcohol-related interactive toxicity
misinformation and promote ARV adherence among al-
cohol drinkers [25]. Clinicians should educate patients
to take ARVs without interruption, even when drinking.
In addition, even if HIV-positive individuals do consume
alcohol, ART is not denied; making this known may re-
sult in more patients receiving ARVs timeously [16].
Treatment options
Findings from the review by Hendershot et al. [21] on
alcohol use and antiretroviral adherence support the
need for intervention to address alcohol in the context
of highly active antiretroviral therapy. These interven-
tions should include strategies to maximise adherence
among those who are unlikely or reluctant to stop con-
suming alcohol.
In order to advise patients appropriately, PHCWs need
knowledge of abstinence from alcohol consumption and
harm reduction models [28]. Treatment options as to
whether abstinence from alcohol consumption or harm
reduction policies are advocated should be clarified, and
indications as to when one or the other is more appro-
priate, specified. Furthermore, knowledge of places to
refer patients identified as requiring specialised treat-
ment for alcohol dependence or addiction should be
readily available for PHCWs.
Harm reduction
Alcohol reduction strategies need to be included in ART
programmes. Instead of simply advising patients to re-
duce alcohol consumption, counsellors should offer
practical advice on how to drink at a level that is less
risky to health. This would include trying to set limits
on the number of drinks, drinking beverages with low
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drinking slowly, and eating before or while drinking
alcohol.
Integration of services
The systematic review by Nakimuli-Mpungu et al. [32]
evaluated estimates of depression, alcohol use or disor-
ders and their association with ART adherence in sub-
Saharan Africa. An important finding was that interven-
tions to improve the mental health of HIV-positive indi-
viduals and to support ART adherence are urgently
needed. In particular, to improve the integration of sub-
stance abuse services, and HIV and AIDS prevention
and treatment, Parry et al. [33] stress the importance of
reducing the vertical nature of HIV and AIDS and alco-
hol programmes. Staff require cross training at HIV and
AIDS and alcohol facilities, with a focus on facilitating
behaviour change, i.e. to help people change behaviour
patterns that are detrimental to health.
Part of standard care
Most (77 %) of a systematic review of 53 clinical re-
search papers by Vagenas et al. [38] found a negative as-
sociation between alcohol consumption and the HIV
continuum of care. The latter represents a sequence of
targets for intervention that can result in viral suppres-
sion, which benefits individuals and society. A recom-
mendation from the study is that problematic alcohol
consumption should be targeted using evidence-based
behavioural and pharmacological interventions to help
increase the proportion of people living with HIV
achieve viral suppression to reduce HIV transmission.
A South African study by Kekwaletse and Morojele
[27] on alcohol drinkers at HIV clinics, which examines
the association between alcohol use and ART non-
adherence points to a need for alcohol-focused behav-
ioural interventions to improve ART adherence. The
study results show that patients are amenable to clinic-
based, brief, motivational interviewing and cognitive be-
havioural therapy-type adherence interventions, deliv-
ered by lay persons in group settings. The use of alcohol
screening and brief interventions (SBI) as early interven-
tions for problem drinkers as part of standard primary
healthcare in ART clinics should be considered. Numer-
ous studies have reported that BIs, which can take place
in various settings, including primary healthcare settings,
and can be implemented by a variety of trained behav-
ioural and primary healthcare providers, are effective in
reducing excessive drinking [26]. BIs consisting of up to
five counselling sessions, even those lasting up to 5 min,
have been found to be effective [3, 4]. Babor et al. [3] ad-
vocated that SBI training packages are necessary for the
widespread dissemination of this intervention. This
programme delivered in the context of a comprehensiveSBI implementation programme was found to be suc-
cessful in improving the providers’ knowledge, attitudes
and practice of SBI for at-risk drinking.
Similar findings were reported in a study by Peltzer
et al. [34] using a SBI training package developed by the
World Health Organization to train primary care nurses
in South Africa. To improve SBI implementation as a rou-
tine practice, the foci should be on training modalities,
clinic organisation and changes in the nurse attitudes. As
part of a standard care procedure, healthcare providers
should routinely screen and counsel patients regarding al-
cohol problems to minimise HIV disease progression [13].
Furthermore, as patients in HIV clinics rarely follow
referrals for outside treatment, Hasin et al. [20] suggest
using smartphone technology after a BI to improve
drinking outcomes in HIV-positive, alcohol dependent
patients. This may offer a way of extending patient en-
gagement with few additional demands on staff time.
In addition to making the HIV and AIDS service users
and providers more attentive to potential alcohol abuse
problems, it is anticipated that this study will generate pub-
lic and health policy makers’ awareness concerning the det-
rimental health effects of excessive alcohol consumption
for treatment-naïve HIV patients and those taking ARVs.
Endnotes
1The CAGE questionnaire, the name being an acro-
nym of its four questions, is a widely used method of
screening for alcoholism.
2Binge drinking can be defined as five or more drinks
in a row for males, or four or more drinks in a row for
females over a few hours, or drinking large amounts
over several days as an established drinking pattern. This
corresponds to 60 g of pure alcohol [34]. The definition
of a standard drink differs from country to country; in
South Africa, it is generally accepted that a drink con-
taining 12 g of alcohol would be regarded as standard.
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